3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Asan Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease [18F]FSPG - Inflammatory Bowel Diseases, Ulcerative Colitis | Phase 2 | Completed | Asan Foundation | 20 | 2018-08-14 | 2020-12-14 |
| A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease [18F]THK-5351 - Alzheimer Disease | Phase 1 | Completed | Asan Foundation | 12 | 2017-05-17 | 2020-12-14 |
| Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism [18F]GP1 - Thromboembolism | Phase 1 | Completed | Asan Foundation | 32 | 2016-08-04 | 2018-05-18 |
Alzheimer Disease (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1) · Nerve Degeneration (1) · Pick Disease of the Brain (1) · Thromboembolism (1)
4-(3-fluoropropyl)glutamic acid (1) · THK5351 (1)
South Korea (3)
JaeEun Kim (1)